Publicaciones (93) Publicaciones en las que ha participado algún/a investigador/a

2005

  1. 17β-Estradiol transcriptionally represses human insulin receptor gene expression causing cellular insulin resistance

    Leukemia Research, Vol. 29, Núm. 1, pp. 79-87

  2. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1β production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: Role of interleukin-1β in neurotoxicity

    Neuroscience, Vol. 135, Núm. 4, pp. 1095-1105

  3. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

    British Journal of Pharmacology, Vol. 144, Núm. 2, pp. 231-241

  4. A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists

    Journal of Medicinal Chemistry, Vol. 48, Núm. 13, pp. 4216-4219

  5. ATP from subplasmalemmal mitochondria controls Ca2+-dependent inactivation of CRAC Ca2+ channels in T lymphocytes: XXVII Congreso nacional de la SEF

    Actualidad en farmacología y terapéutica, Vol. 3, Núm. 4, pp. 292-294

  6. Activación de la Calcio Calmodulina quinasa II. CaMKII, por el uridin nucleósido difosfato, UDP, en neuronas granulares de cerebelo

    Anales de la Real Academia Nacional de Farmacia, Núm. 2, pp. 439-449

  7. Activación de la calcio calmodulina quinasa II, CaMKII, por el uridin nucleósido difosfato, UDP, en neuronas granulares de cerebelo

    Anales de la Real Academia Nacional de Farmacia, Vol. 71, Núm. 2, pp. 439-449

  8. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

    FASEB Journal, Vol. 19, Núm. 10, pp. 1338-1340

  9. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma

    Current Opinion in Investigational Drugs, Vol. 6, Núm. 1, pp. 76-80

  10. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors

    European Journal of Pharmacology, Vol. 511, Núm. 1, pp. 9-19

  11. Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease

    Brain Research, Vol. 1050, Núm. 1-2, pp. 210-216

  12. Asociación de hemoglobinopatía S y alfatalasemia. Análisis de 45 casos

    Medicina Clinica, Vol. 124, Núm. 19, pp. 726-729

  13. CB1 and CB2 cannabinoid receptor binding studies based on modeling and mutagenesis approaches

    Mini-Reviews in Medicinal Chemistry, Vol. 5, Núm. 7, pp. 651-658

  14. Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice

    Brain Research, Vol. 1046, Núm. 1-2, pp. 195-206

  15. Cannabinoid control of motor function at the Basal Ganglia

    Handbook of Experimental Pharmacology, Vol. 168, pp. 479-507

  16. Cannabinoid tolerance and dependence: A review of studies in laboratory animals

    Pharmacology Biochemistry and Behavior

  17. Cannabinoids and ceramide: Two lipids acting hand-by-hand

    Life Sciences

  18. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

    Neurobiology of Disease, Vol. 19, Núm. 1-2, pp. 96-107

  19. Cerebellar astrocytes co-express several ADP receptors. Presence of functional P2Y13-like receptors

    Purinergic Signalling, Vol. 1, Núm. 2, pp. 153-159

  20. Characterization of a functional P2X7-like receptor in cerebellar granule neurons from P2X7 knockout mice

    FEBS Letters, Vol. 579, Núm. 17, pp. 3783-3788